170 related articles for article (PubMed ID: 11502857)
21. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.
Wańkowicz-Kalińska A; van den Wijngaard RM; Tigges BJ; Westerhof W; Ogg GS; Cerundolo V; Storkus WJ; Das PK
Lab Invest; 2003 May; 83(5):683-95. PubMed ID: 12746478
[TBL] [Abstract][Full Text] [Related]
22. Physiopathology and genetics of vitiligo.
Passeron T; Ortonne JP
J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
[TBL] [Abstract][Full Text] [Related]
23. Review of the etiopathomechanism of vitiligo: a convergence theory.
Le Poole IC; Das PK; van den Wijngaard RM; Bos JD; Westerhof W
Exp Dermatol; 1993 Aug; 2(4):145-53. PubMed ID: 8162332
[TBL] [Abstract][Full Text] [Related]
24. Melanocyte destruction and repopulation in vitiligo.
Norris DA; Horikawa T; Morelli JG
Pigment Cell Res; 1994 Aug; 7(4):193-203. PubMed ID: 7855062
[No Abstract] [Full Text] [Related]
25. An immunohistological study of cutaneous lymphocytes in vitiligo.
Badri AM; Todd PM; Garioch JJ; Gudgeon JE; Stewart DG; Goudie RB
J Pathol; 1993 Jun; 170(2):149-55. PubMed ID: 8345407
[TBL] [Abstract][Full Text] [Related]
26. Melanoma, vitiligo and topographic antigens.
James DB
Melanoma Res; 1993 Feb; 3(1):76-7. PubMed ID: 8471841
[No Abstract] [Full Text] [Related]
27. Melanocyte-specific cell mediated immune response in vitiliginous Smyth line chickens.
Wang X; Erf GF
J Autoimmun; 2003 Sep; 21(2):149-60. PubMed ID: 12935784
[TBL] [Abstract][Full Text] [Related]
28. Vitiligo: Pathogenesis, clinical variants and treatment approaches.
Iannella G; Greco A; Didona D; Didona B; Granata G; Manno A; Pasquariello B; Magliulo G
Autoimmun Rev; 2016 Apr; 15(4):335-43. PubMed ID: 26724277
[TBL] [Abstract][Full Text] [Related]
29. [Autoantibodies in vitiligo. Clinical significance].
Morgan M; Castells A; Ramírez A
Med Cutan Ibero Lat Am; 1986; 14(2):139-42. PubMed ID: 3528710
[TBL] [Abstract][Full Text] [Related]
30. Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.
Uchi H; Stan R; Turk MJ; Engelhorn ME; Rizzuto GA; Goldberg SM; Wolchok JD; Houghton AN
Adv Immunol; 2006; 90():215-41. PubMed ID: 16730265
[TBL] [Abstract][Full Text] [Related]
31. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.
Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862
[TBL] [Abstract][Full Text] [Related]
32. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity.
Norris DA; Kissinger RM; Naughton GM; Bystryn JC
J Invest Dermatol; 1988 Jun; 90(6):783-9. PubMed ID: 3373009
[TBL] [Abstract][Full Text] [Related]
33. Vitiligo in an Italian outpatient center: a clinical and serologic study of 204 patients in Tuscany.
Berti S; Bellandi S; Bertelli A; Colucci R; Lotti T; Moretti S
Am J Clin Dermatol; 2011 Feb; 12(1):43-9. PubMed ID: 21110525
[TBL] [Abstract][Full Text] [Related]
34. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo.
al Badri AM; Foulis AK; Todd PM; Gariouch JJ; Gudgeon JE; Stewart DG; Gracie JA; Goudie RB
J Pathol; 1993 Feb; 169(2):203-6. PubMed ID: 8095298
[TBL] [Abstract][Full Text] [Related]
35. Anatomically distinct fibroblast subsets determine skin autoimmune patterns.
Xu Z; Chen D; Hu Y; Jiang K; Huang H; Du Y; Wu W; Wang J; Sui J; Wang W; Zhang L; Li S; Li C; Yang Y; Chang J; Chen T
Nature; 2022 Jan; 601(7891):118-124. PubMed ID: 34912121
[TBL] [Abstract][Full Text] [Related]
36. The change of melanocyte cytotoxicity after systemic steroid treatment in vitiligo patients.
Hann SK; Kim HI; Im S; Park YK; Cui J; Bystryn JC
J Dermatol Sci; 1993 Dec; 6(3):201-5. PubMed ID: 8136318
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo.
Wang X; Erf GF
J Autoimmun; 2004 Feb; 22(1):21-30. PubMed ID: 14709410
[TBL] [Abstract][Full Text] [Related]
38. Profiles of pulp infiltrating lymphocytes at various times throughout feather regeneration in Smyth line chickens with vitiligo.
Shresta S; Smyth JR; Erf GF
Autoimmunity; 1997; 25(4):193-201. PubMed ID: 9344327
[TBL] [Abstract][Full Text] [Related]
39. [Immunological changes in common vitiligo].
Vignale R; Paciel J; Calandria L
Med Cutan Ibero Lat Am; 1988; 16(4):343-7. PubMed ID: 3068448
[TBL] [Abstract][Full Text] [Related]
40. Vitiligo: pathogenetic hypotheses and targets for current therapies.
Guerra L; Dellambra E; Brescia S; Raskovic D
Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
